Saxagliptin
CAS 361442-04-8
Visão geral
Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic of the dipeptidyl peptidase-4 inhibitor class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug
A Anant Labs fabrica e fornece impurezas de Saxagliptin de alta qualidade para o mercado global. Nossas impurezas EP de Saxagliptin são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
